SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT-Case Report

被引:3
作者
Sirak, Igor [1 ,2 ]
Laco, Jan [2 ,3 ]
Vosmikova, Hana [2 ,3 ]
Mell, Loren K. [4 ]
Herrera, Fernanda G. [5 ]
Senkerikova, Maria [2 ,6 ]
Vosmik, Milan [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med, Dept Radiotherapy & Oncol, Hradec Kralove, Czech Republic
[2] Charles Univ Prague, Univ Hosp, Hradec Kralove, Czech Republic
[3] Charles Univ Prague, Fac Med, Fingerland Dept Pathol, Hradec Kralove, Czech Republic
[4] Univ Calif San Diego, Dept Radiat Med & Appl Sci, San Diego, CA 92103 USA
[5] Univ Lausanne, Lausanne Univ Hosp, Ludwig Inst Canc Res, Lausanne, Switzerland
[6] Charles Univ Prague, Fac Med, Dept Med Genet, Hradec Kralove, Czech Republic
关键词
cervical cancer; diagnostic biomarker; predictive marker; gynecological cancer; high-risk; personalized treatment; case report; SMALL-CELL-CARCINOMA; HYPERCALCEMIC TYPE SCCOHT; SMARCA4; MUTATIONS; OVARY; GERMLINE; EXPRESSION; CANCERS; GENES;
D O I
10.3389/pore.2021.1610003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Small cell carcinoma of hypercalcemic type (SCCOHT) is a rare gynaecological neoplasm, originating mostly in the ovaries. Cervical origin of this very aggressive malignancy with unknown histogenesis is an extremely rare condition, without published management recommendations. Alterations in SMARCA4 gene are supposed to play the major role in SCCOHT oncogenesis and their identification is crucial for the diagnosis. Adequate genetic counselling of the patients and their families seems to be of great importance. Optimal management and treatment approaches are not known yet but may extremely influence the prognosis of young female patients that suffer from this very resistant disease. Nowadays, a translational research seems to be the key for the further diagnostic and treatment strategies of SCCOHT. The purpose of the case report is to provide practical information and useful recommendations on the diagnosis, management, and treatment of SMARCA4-deficient carcinoma of the uterine cervix resembling SCCOHT.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Treatment for SMARCA4-deficient carcinoma of uterine cervix
    Yokoe, Takuya
    Oku, Kaede
    Noda, Yuri
    Kita, Masato
    BMJ CASE REPORTS, 2025, 18 (01)
  • [2] SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities
    Kolin, David L.
    Quick, Charles M.
    Dong, Fei
    Fletcher, Christopher D. M.
    Stewart, Colin J. R.
    Soma, Anita
    Hornick, Jason L.
    Nucci, Marisa R.
    Howitt, Brooke E.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (02) : 263 - 270
  • [3] SMARCA4-deficient dedifferentiated endometrioid carcinoma: a case report
    Huang, Ruihong
    Chen, Lvxuan
    Pan, Canyu
    Fang, Xueting
    ASIAN JOURNAL OF SURGERY, 2023, 46 (12) : 5484 - 5485
  • [4] SMARCA4-deficient uterine adnexal tumor with ascites: A case report and literature review
    Li, Xiu-Feng
    Zhang, Yu-Ping
    Wei, Li-Li
    Wang, Zheng-Jiang
    Yang, Mai-Qing
    ONCOLOGY LETTERS, 2024, 28 (02)
  • [5] Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma
    Gao, Jie
    Fan, Ruirui
    Chen, Dahong
    Hou, Jinlin
    Chen, Hanlin
    Lu, Mingzhi
    DIAGNOSTIC PATHOLOGY, 2023, 18 (01)
  • [6] SMARCA4-deficient undifferentiated thoracic tumor: A case report
    Kwon, Hee Jung
    Jang, Min Hye
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (11)
  • [7] SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma
    Kolin, David L.
    Dong, Fei
    Baltay, Michele
    Lindeman, Neal
    MacConaill, Laura
    Nucci, Marisa R.
    Crum, Christopher P.
    Howitt, Brooke E.
    MODERN PATHOLOGY, 2018, 31 (09) : 1442 - 1456
  • [8] SMARCA4-deficient uterine tumors in young women: response to immune checkpoint inhibitors
    Suzui, Riku
    Taki, Mana
    Kitamura, Sachiko
    Sunada, Masumi
    Yamanoi, Koji
    Murakami, Ryusuke
    Yamaguchi, Ken
    Hamanishi, Junzo
    Minamiguchi, Sachiko
    Mandai, Masaki
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 515 - 519
  • [9] Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report
    Iijima, Yuki
    Sakakibara, Rie
    Ishizuka, Masahiro
    Honda, Takayuki
    Shirai, Tsuyoshi
    Okamoto, Tsukasa
    Tateishi, Tomoya
    Sakashita, Hiroyuki
    Tamaoka, Meiyo
    Takemoto, Akira
    Kumaki, Yuichi
    Ikeda, Sadakatsu
    Miyazaki, Yasunari
    IMMUNOTHERAPY, 2020, 12 (08) : 563 - 569
  • [10] Thoracic SMARCA4-deficient undifferentiated tumor
    Jiang, Jiapeng
    Chen, Zhixin
    Gong, Jiali
    Han, Na
    Lu, Hongyang
    DISCOVER ONCOLOGY, 2023, 14 (01)